Short Interest in Halberd Co. (OTCMKTS:HALB) Declines By 96.9%

Halberd Co. (OTCMKTS:HALB) saw a significant drop in short interest in December. As of December 31st, there was short interest totalling 700 shares, a drop of 96.9% from the December 15th total of 22,300 shares. Based on an average trading volume of 1,645,800 shares, the short-interest ratio is currently 0.0 days.

Halberd Trading Down 11.6 %

Shares of OTCMKTS:HALB traded down $0.00 during mid-day trading on Tuesday, reaching $0.00. The stock had a trading volume of 957,495 shares, compared to its average volume of 421,349. Halberd has a 1 year low of $0.00 and a 1 year high of $0.01.

Halberd Company Profile

Halberd Corporation, a biotech company, develops treatments for neurodegenerative diseases. It offers treatments for post traumatic stress disorder/chronic traumatic encephalopathy, Alzheimer's and Parkinson's disease, cancer, blood-borne, and cerebrospinal fluid related diseases. The company was incorporated in 2009 and is based in Jackson Center, Pennsylvania.